Document:

NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
        CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
        STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE COMPANY COUNSEL OR COUNSEL SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
        UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.  NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
        SECURITIES.

      

      

      

      

      Principal Amount: US$850,000.00                   Issue Date: October 7, 2019

      Purchase Price: US$850,000.00

          

      

      CONVERTIBLE PROMISSORY NOTE

      

      

      FOR VALUE RECEIVED, BIORESTORATIVE
          THERAPIES, INC., a Delaware corporation (hereinafter called the “Borrower”), hereby promises to pay to the order of AUCTUS FUND, LLC, a
        Delaware limited liability company, or registered assigns (the “Holder”) the principal sum of $850,000.00 (the “Principal Amount”), together with interest at the rate of twelve percent (12%) per annum from the date hereof (the “Issue Date’) until
        the same becomes due and payable, whether at maturity or upon acceleration by prepayment or otherwise, as set forth herein (the “Note”). The maturity date shall be six (6) months from the Issue Date (the “Maturity Date”), and is the date upon which
        the principal sum, as well as any accrued and unpaid interest and other fees shall be due and payable. This Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest on this
        Note, which is not paid when due, shall bear interest at the rate of the lesser of (i) eighteen percent (18%) per annum or (ii) the maximum amount allowed by law from the due date thereof until the same is paid (the “Default Interest”). Interest
        shall commence accruing on the date that the Note is fully paid and shall be computed on the basis of a 365-day year and the actual number of days elapsed. All payments due hereunder (to the extent not converted into the Borrower’s common stock,
        $0.001 par value per share (the “Common Stock”) in accordance with the terms hereof) shall be made in lawful money of the United States of America. All payments shall be made at such address as the Holder shall hereafter give to the Borrower by
        written notice made in accordance with the provisions of this Note. Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a business day, the same shall instead be due on the next succeeding day which is a
        business day and, in the case of any interest payment date which is not the date on which this Note is paid in full, the extension of the due date thereof shall not be taken into account for purposes of determining the amount of interest due on
        such date. As used in this Note, the term “business day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York are authorized or required by law or executive order to remain closed.
        Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in that certain Securities Purchase Agreement dated the date hereof, pursuant to which this Note was originally issued (the “Purchase Agreement”).

      

      

      

      This Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to
        preemptive rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.

      

      

      The following terms shall apply to this Note:

      

      

      ARTICLE I. CONVERSION RIGHTS

      

      

      1.1 Conversion Right.  The Holder shall have the right at any  time following the 180th
          calendar day after the Issue Date to convert all or any part of the outstanding and unpaid principal amount of this Note into fully paid and non-assessable shares of Common Stock, as such Common Stock exists on the Issue Date, or any shares of
          capital stock or other securities of the Borrower into which such Common Stock shall hereafter be changed or reclassified at the Conversion Price (as defined below) determined as provided herein (a “Conversion”); provided, however, that in no event shall the Holder be entitled to convert any portion of
          this Note in excess of that portion of this Note upon conversion of which the sum of (1) the number  of shares of Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially
          owned through the ownership of the unconverted portion of the Notes or the unexercised or unconverted portion of any other security of the Borrower subject to a limitation on conversion or exercise analogous to the limitations contained herein)
          and (2) the number of shares of Common Stock issuable upon the conversion  of the portion of this Note with respect to which the determination of this proviso is being made, would result in beneficial ownership by the Holder and its affiliates of
          more than 4.99% of the outstanding shares of Common Stock. For purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as
          amended (the “Exchange Act”), and Regulations 13D-G thereunder,  except  as  otherwise  provided  in  clause  (1)  of  such  proviso,  provided, further, however, that the limitations on conversion may be waived
          by the Holder (up to a maximum of 9.99%) upon, at the election of the Holder, not less than 61 days’ prior notice to the Borrower, and the provisions of the conversion limitation shall continue to apply until such 61st day (or such later date,
          as  determined by the Holder, as may be specified in such notice of waiver). The number of shares  of Common Stock to be issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the
          applicable Conversion Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit A (the “Notice of Conversion”), delivered to the Borrower by the Holder in accordance with Section 1.4 below;
          provided that the Notice of Conversion is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to the Borrower before 6:00 p.m., New York, New York time on such conversion date (the
          “Conversion Date”). The term “Conversion Amount” means, with respect to any conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion plus (2) at the Holder’s option, accrued and unpaid interest, if any, on such principal amount at the interest  rates provided in this Note to the Conversion Date, provided, however, that the Borrower shall
          have the right to pay any or all interest in cash plus (3) at the Holder’s option, Default Interest, if any, on the amounts referred to in the immediately
          preceding clauses (1) and/or (2) plus (4) at the Holder’s option, any amounts owed to the Holder pursuant to Sections 1.3 and 1.4(g) hereof.

      

      

      1.2 Conversion Price.

      

      

      

      (a) Calculation of Conversion Price. Subject to the adjustments described herein, the
          conversion price (the “Conversion Price”) shall be the lesser of (i) the lowest Trading Price (as defined below) on the Issue Date or (ii) Variable Conversion Price (as defined herein) (subject to equitable adjustments for reverse stock splits,
          stock splits, stock dividends or rights offerings by the Borrower relating to the Borrower’s securities or the securities of any subsidiary of the Borrower, combinations, recapitalization, reclassifications, extraordinary distributions and
          similar events). The "Variable Conversion Price" shall mean 58% multiplied by the Market Price (as defined herein) (representing a discount rate of 42%); provided, however, that in no event shall the Variable Conversion Price be less than one
          dollar and fifty cents ($1.50) (the “Floor Price”) except as provided herein (subject to equitable adjustment as set forth above).  Notwithstanding anything contained herein to the contrary, if an Event of Default (as defined in this Note) under
          Section 3.1 of this Note occurs, the Floor Price shall no longer apply.  “Market Price” means the lowest Trading Price for the Common Stock during the ten (10) Trading Day period ending on the last complete Trading Day prior to the Conversion
          Date. “Trading Price” means, for any security as of any date, the closing price on the OTC Pink, OTCQB, or applicable trading market (the “OTCQB”) as reported by a reliable reporting service (“Reporting Service”) designated by the Holder (i.e.
          www.Nasdaq.com) or, if the OTCQB is not the principal trading market for such security, the average of the closing bid and asked prices for such security on the principal securities exchange or trading market where such security is listed or
          traded or, if no closing bid price for such security is available in any of the foregoing manners, the average of the closing bid and asked prices of any market makers for such security that are quoted on the OTC Markets. If the Trading Price
          cannot be calculated for such security on such date in the manner provided above, the Trading Price shall be the fair market value as mutually determined by the Borrower and the holders of a majority in interest of the Notes being converted for
          which the calculation of the Trading Price is required in order to determine the Conversion Price of such Notes.  “Trading Day” shall mean any day on which the Common Stock is tradable for any period on the OTCQB, or on the principal securities
          exchange or other securities market on which the Common Stock is then being traded.

      

      

      The Borrower shall be responsible for the fees of its transfer agent and all DTC fees associated with any such issuance.  Holder shall
        be entitled to deduct $250.00 from the conversion amount in each Notice of Conversion to cover Holder’s deposit fees associated with each Notice of Conversion.

      

      

      If at any time the Conversion Price as determined hereunder for any conversion would be less than the par value of the Common Stock,
        then at the sole discretion of the Holder, the Conversion Price hereunder may equal such par value for such conversion and the Conversion Amount for such conversion may be increased to include Additional Principal, where “Additional Principal”
        means such additional amount to be added to the Conversion Amount to the extent necessary to cause the number of conversion shares issuable upon such conversion to equal the same number of conversion shares as would have been issued had the
        Conversion Price not been adjusted by the Holder to the par value price.

      

      

      1.3 Authorized Shares. The Borrower covenants that during the period the conversion
          right exists, the Borrower will reserve from its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock upon the full conversion of this Note issued pursuant to
          the Purchase Agreement.  The Borrower is required at all times to have authorized and reserved three (3) times the number of shares that is actually issuable upon full conversion of the Note (based on the Variable Conversion Price without regard
          to the Floor Price) (the “Reserved Amount”). The Reserved Amount shall be increased from time to time in accordance with the Borrower’s obligations hereunder. The Borrower represents that upon issuance, such shares will be duly and validly
          issued, fully paid and non-assessable. In addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares of Common Stock into which the Notes shall be convertible at the
          then current Conversion Price, the Borrower shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive rights, for conversion of the
          outstanding Note.  The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall
          constitute full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock in accordance with the terms and conditions of this
          Note.

      

      

      If, at any time the Borrower does not maintain the Reserved Amount, and such failure continues unremedied for a period of fourteen
        (14) days following receipt of written notice thereof from the Holder, it will be considered an Event of Default under Section 3.2 of the Note.

      

      

      1.4 Method of Conversion.

      

      

      (a) Mechanics of Conversion. Subject to Section 1.1, this Note may be converted by the
          Holder, in whole or in part, at any time from time to time after the 180th calendar day after the Issue Date, by (A) submitting to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication
          dispatched on the Conversion Date prior to 5:00 p.m., New York, New York time) and (B) subject to Section 1.4(b), surrendering this Note at the principal office of the Borrower.

      

      

      (b) Surrender of Note Upon Conversion. Notwithstanding anything to the contrary set
          forth herein, upon conversion of this Note in accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire unpaid principal amount of this Note is so converted. The Holder
          and the Borrower shall maintain records showing the principal amount so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower, so as not to require physical surrender of
          this Note upon each such conversion. In the event of any dispute or discrepancy, such records of the Borrower shall, prima facie, be controlling and determinative in the absence of manifest error. Notwithstanding the foregoing, if any portion of
          this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders this Note to the Borrower, whereupon the Borrower will forthwith issue and deliver upon the order of the Holder a new Note of
          like tenor, registered as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing in the aggregate the remaining unpaid principal amount of this Note. The Holder and any assignee, by acceptance of this
          Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note represented by this Note may be less than the amount stated
          on the face hereof.

      

      

      (c) Payment of Taxes. The Borrower shall not be required to pay any tax which may be
          payable in respect of any transfer involved in the issue and delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other than that of the Holder (or in street name), and the Borrower shall not be
          required to issue or deliver any such shares or other securities or property unless and until the person or persons (other   than the Holder or the custodian in whose street name such shares are to be held for the Holder’s account) requesting the
          issuance thereof shall have paid to the Borrower the amount of any such tax or shall have established to the satisfaction of the Borrower that such tax has been paid.

      

      

      (d) Delivery of Common Stock Upon Conversion. Upon receipt by the Borrower from the
          Holder of a facsimile transmission or e-mail (or other reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section 1.4, the Borrower shall issue and deliver or cause to be
          issued and delivered to or upon the order of the Holder certificates for the Common Stock issuable upon such conversion within three (3) business days after such receipt (the “Deadline”) (and, solely in the case of conversion of the entire unpaid
          principal amount hereof, surrender of this Note) in accordance with the terms hereof and the Purchase Agreement.

      

      

      (e) Obligation of Borrower to Deliver Common Stock. Upon receipt by  the Borrower of a
          Notice of Conversion, the Holder shall be deemed to be the holder of record of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on this Note shall be reduced to reflect
          such conversion, and, unless the Borrower defaults on its obligations under this Article I, all rights with respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Stock or other
          securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion as provided herein, the Borrower’s obligation to issue and deliver the certificates for Common Stock shall be absolute
          and unconditional, irrespective of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery of any judgment  against any person or any action to enforce the same, any
          failure or delay in the enforcement of any other obligation of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder of any obligation to the
          Borrower, and irrespective of any other circumstance which might otherwise limit such obligation of the Borrower to the Holder in connection with such conversion. The Conversion Date specified in the Notice of Conversion shall be the Conversion
          Date so long as the Notice of Conversion is received by the Borrower before 5:00 p.m., New York, New York time, on such date.

      

      

      (f) Delivery of Common Stock by Electronic Transfer. In lieu of delivering physical
          certificates representing the Common Stock issuable upon conversion, provided the Borrower is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of the Holder and its compliance
          with the provisions contained in Sections 1.1 and 1.3 and in this Section 1.4, the Borrower shall use its commercially reasonable best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the
          Holder by crediting the account of Holder’s Prime Broker with DTC through its Deposit Withdrawal At Custodian (“DWAC”) system.

      

      

      (g) DTC Eligibility & Market Loss. If the Borrower fails to maintain its status as
          “DTC Eligible” for any reason, or, if the Conversion Price is less than $0.01 at any time while this Note is outstanding, the principal amount of the Note shall increase by Fifteen Thousand and No/100 United States Dollars ($15,000) (under
          Holder’s and Borrower’s expectation that any principal amount increase will tack back to the Issue Date).  In addition, the Variable Conversion Price shall be redefined to mean forty percent (40%) multiplied by the Market Price, subject to
          adjustment as provided in this Note.

      

      

      (h) Failure to Deliver Common Stock Prior to Deadline. Without in any way limiting the
          Holder’s right to pursue other remedies, including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of this Note is not delivered by the Deadline, the Borrower shall pay to
          the Holder $500 per day in cash, as liquidated damages, for each day beyond the Deadline that the Borrower fails to deliver such Common Stock. Such cash amount shall be paid to Holder by the fifth day of the month following the month in which it
          has accrued or, at the option of the Holder (by written notice to the Borrower by the first day of the month following the month in which it has accrued), shall be added to the principal amount of this Note, in which event interest shall accrue
          thereon in accordance with the terms of this Note and such additional principal amount shall be convertible into Common Stock in accordance with the terms of this Note.  The Borrower agrees that the right to convert is a valuable right to the
          Holder. The damages resulting from a failure, attempt to frustrate, interference with such conversion right are difficult if not impossible to qualify.  Accordingly
          the parties acknowledge that the liquidated damages provision contained in this Section 1.4(h) are justified.

      

      

      Rescindment of a Notice of Conversion.  If (i) the Borrower
        fails to respond to Holder within one (1) business day from the Conversion Date confirming the details of Notice of Conversion, (ii) the Borrower fails to provide any of the shares of the Borrower’s Common Stock requested in the Notice of
        Conversion within three (3) business days from the date of receipt of the Note of Conversion, (iii) the Holder is unable to procure a legal opinion required to have the shares of the Borrower’s Common Stock issued unrestricted and/or deposited to
        sell for any reason related to the Borrower’s standing, (iv) the Holder is unable to deposit the shares of the Borrower’s Common Stock requested in the Notice of Conversion for any reason related to the Borrower’s standing, (v) at any time after a
        missed Deadline, at the Holder’s sole discretion, or (vi) if OTC Markets changes the Borrower's designation to ‘Limited Information’ (Yield), ‘No Information’ (Stop Sign), ‘Caveat Emptor’ (Skull & Crossbones), ‘OTC’, ‘Other OTC’ or ‘Grey
        Market’ (Exclamation Mark Sign) or other trading restriction on the day of or any day after the Conversion Date, the Holder maintains the option and sole discretion to rescind the Notice of Conversion (“Rescindment”) with a “Notice of Rescindment.”

      

      

      1.5  Concerning the Shares. The shares of Common Stock  issuable upon conversion of this Note may not be sold or transferred unless (i) such shares are sold pursuant to an
          effective registration statement under the Act or (ii) the Borrower or its transfer agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel in comparable
          transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor rule)
          (“Rule 144”) or (iv) such shares are transferred to an “affiliate” (as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 1.5 and who is an Accredited Investor. Except as
          otherwise provided in the Purchase Agreement (and subject to the removal provisions set forth below), until such time as the shares of Common Stock issuable upon conversion of this Note have been registered under the Act or otherwise may be sold
          pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate for shares of Common Stock issuable upon conversion of this Note that has not been so included
          in an effective registration statement or that has not been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:

      

      

      “NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE
        SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE
        ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE COMPANY COUNSEL OR COUNSEL SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE
        FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR
        FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

      

      

      The legend set forth above shall be removed and the Borrower shall issue to the Holder a new certificate therefore free of any
        transfer legend if (i) the Borrower or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such
        Common Stock may be made without registration under the Act, which opinion shall be reasonably accepted by the Borrower so that the sale or transfer is effected
        or (ii) in the case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by the Holder under an effective registration statement filed under the Act or otherwise may be sold pursuant to Rule  144 without
        any restriction as to the number of securities as of a particular date that can then be immediately sold. In the event that the Borrower does not accept the opinion of counsel provided by the Holder with respect to the transfer of Securities
        pursuant to an exemption from registration, such as Rule 144 or Regulation S, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2 of the Note.  The foregoing is subject to the requirements of Section 4(a)(1) of the
        Act and Rule 144.

      

      

      1.6 Effect of Certain Events.

      

      

      (a) Adjustment Due to Merger, Consolidation, Etc.  If, at any time when this Note is
          issued and outstanding and prior to conversion of all of the Notes, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar event, as a result of which shares of Common Stock of the
          Borrower shall be changed into the same or a different number of shares of another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially all of the assets of the
          Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions
          specified herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which the Holder would have been entitled to receive in such transaction had this Note been converted in
          full immediately prior to such transaction (without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect to the rights and interests of the Holder of this Note to the
          end that the provisions hereof (including, without limitation, provisions for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable, as nearly as may be practicable in
          relation to any securities or assets thereafter deliverable upon the conversion hereof.  The Borrower shall not affect any transaction described in this Section 1.6(a) unless (a) it first gives, to the extent practicable, thirty (30) days prior
          written notice (but in any event at least fifteen (15) days prior written notice) of the record date of the special meeting of shareholders to approve, or if there is no such record date, the consummation of, such merger, consolidation, exchange
          of shares, recapitalization, reorganization or other similar event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b) the resulting successor or acquiring entity (if not the Borrower) assumes by
          written instrument the obligations of this Section 1.6(a).  The above provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.

      

      

      (b) Adjustment Due to Distribution.  If the Borrower shall declare or make any
          distribution of its assets (or rights to acquire its assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend or distribution to the Borrower’s shareholders in cash or
          shares (or rights to acquire shares) of capital stock of a subsidiary (i.e., a spin-off)) (a “Distribution”), then the Holder of this Note shall be entitled, upon any conversion of this Note after the date of record for determining shareholders
          entitled to such Distribution, to receive the amount of such assets which would have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder of such shares of Common
          Stock on the record date for the determination of shareholders entitled to such Distribution.

      

      

      (c) Purchase Rights.  If, at any time when any Notes are issued and outstanding, the
          Borrower issues any convertible securities or rights to purchase stock, warrants, securities or other property (the “Purchase Rights”) pro rata to the record holders of any class of Common Stock, then the Holder of this Note will be entitled to
          acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without
          regard to any limitations on conversion contained herein) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the date as of which the record holders of
          Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

      

      

      (d) Notice of Adjustments.  Upon the occurrence of each adjustment or readjustment of
          the Conversion Price as a result of the events described in this Section 1.6, the Borrower, at its expense, shall promptly compute such adjustment or readjustment and prepare and furnish to the Holder a certificate setting forth such adjustment
          or readjustment and showing in detail the facts upon which such adjustment or readjustment is based.  The Borrower shall, upon the written request at any time of the Holder, furnish to such Holder a like certificate setting forth (i) such
          adjustment or readjustment, (ii) the Conversion Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon conversion of the Note.

      

      

      1.7 Status as Shareholder. Upon submission of a Notice of Conversion by a Holder,
          subject to Section 1.3, (i) the shares covered thereby (other than the shares, if any, which cannot be issued because their issuance would exceed such Holder’s allocated portion of the Reserved Amount or Maximum Share Amount) shall be deemed
          converted into shares of Common Stock and (ii) the Holder’s rights as a Holder of such converted portion of this Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies
          provided herein or otherwise available at law or in equity to such Holder because of a failure by the Borrower to comply with the terms of this Note. Notwithstanding the foregoing, if a Holder has not received certificates for all shares of
          Common Stock prior to the tenth (10th) business day after the expiration of the Deadline with respect to a conversion of any portion of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of Common
          Stock by so notifying the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted portions of this Note and the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or,
          if the Note has not been surrendered, adjust its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall retain all of its rights and remedies (including, without limitation, (i) the right to
          receive Conversion Default Payments pursuant to Section 1.3 to the extent required thereby for such Conversion Default and any subsequent Conversion Default and (ii) the right to have the Conversion Price with respect to subsequent conversions
          determined in accordance with Section 1.3) for the Borrower’s failure to convert this Note.

      

      

      1.8 Prepayment.  Subject to the terms of this Note, and provided that an Event of Default has not occurred under this Note, the Borrower may prepay the amounts outstanding hereunder pursuant to the following terms and conditions:

      

      

      (a) At any time during the period beginning on the Issue Date and ending on the date which is ninety (90) days following the Issue Date, the Borrower shall have the right,
          exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note (principal and accrued interest), in full by making a payment to the Holder of an amount in cash equal to 110%,
          multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and unpaid interest on the unpaid principal amount of
          this Note plus (y) Default Interest, if any.

      

      

      (b) At any time during the period beginning the day which is ninety one (91) days following the Issue Date and ending on the date which is one hundred eighty (180) days following
          the Issue Date, the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note to prepay the outstanding Note (principal and accrued interest), in full by making a payment to
          the Holder of an amount in cash equal to 125%, multiplied by the sum of: (w) the then outstanding principal amount of this Note plus (x) accrued and
          unpaid interest on the unpaid principal amount of this Note plus (y) Default Interest, if any.

      

      

      (c) After the expiration of one hundred eighty (180) days following the date of the Note, the Borrower shall have no right of prepayment.

      

      

      1.9 Any notice of prepayment hereunder (an “Optional Prepayment Notice”) shall be delivered to the Holder of the Note at its registered addresses and shall state: (1) that the
          Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall be not more than three (3) Trading Days from the date of the Optional Prepayment Notice.  On the date fixed for prepayment (the “Optional Prepayment
          Date”), the Borrower shall make payment of the applicable prepayment amount to or upon the order of the Holder as specified by the Holder in writing to the Borrower at least one (1) business day prior to the Optional Prepayment Date.  If the
          Borrower delivers an Optional Prepayment Notice and fails to pay the applicable prepayment amount due to the Holder of the Note within two (2) business days following the Optional Prepayment Date, the Borrower shall forever forfeit its right to
          prepay the Note pursuant to this Section 1.9.

      

      

      ARTICLE II.  CERTAIN COVENANTS

      

      

      2.1 Distributions on Capital Stock. So long as the Borrower shall have any obligation
          under this Note, the Borrower shall not without the Holder’s written consent (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash, property or other securities) on shares of capital stock other than
          dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution in respect of its capital stock except for distributions
          pursuant to any shareholders’ rights plan which is approved by a majority of the Borrower’s disinterested directors.

      

      

      2.2 Restriction on Stock Repurchases. So long as the Borrower shall have any obligation
          under this Note, the Borrower shall not without the Holder’s written consent redeem, repurchase or otherwise acquire (whether for cash or in exchange for property   or other securities or otherwise) in any one transaction or series of related
          transactions any shares of capital stock of the Borrower or, other than in exchange for securities of the Borrower, any warrants, rights or options to purchase or acquire any such shares.

      

      

      ARTICLE III. EVENTS OF DEFAULT

      

      

      If any of the following events of default (each, an “Event of Default”) shall occur:

      

      

      3.1 Failure to Pay Principal or Interest. The Borrower fails to pay the principal hereof
          or interest thereon when due on this Note, whether at maturity, upon acceleration or otherwise, and such breach continues for a period of five (5) days.

      

      

      3.2 Conversion and the Shares.  The Borrower (i) fails to issue shares of Common Stock to the Holder (or announces or threatens in writing that it will not honor its
            obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of this Note, (ii) fails to
          transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) any certificate for shares of Common Stock issued to the
          Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, (iii) directs its transfer agent not to transfer or delays, impairs,
            and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for shares of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when
            required by this Note, (iv) fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect
            thereof) on any certificate for any shares of Common Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement, statement or threat that it does not
            intend to honor the obligations described in this paragraph) and any such failure shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing) for three (3) business
            days after the Holder shall have delivered a Notice of Conversion, (v) fails to remain current in its obligations to its transfer agent, (vi) causes a conversion of this Note is delayed, hindered or frustrated due to a balance owed by the
            Borrower to its transfer agent, (vii) fails to repay Holder, within forty eight (48) hours of a demand from the Holder, any amount of funds advanced by Holder to Borrower’s transfer agent in order to process a conversion, and/or (viii) fails to
            maintain the Reserved Amount.

      

      

      3.3 Breach of Covenants. The Borrower breaches any material covenant or other material
          term or condition contained in this Note and any collateral documents (including but not limited to the Purchase Agreement) and such breach continues for a period of ten (10) days after written notice thereof to the Borrower from the Holder.

      

      

      3.4 Breach of Representations and Warranties.  Any representation or warranty of the
          Borrower made herein or in any agreement, statement or certificate given in writing pursuant hereto or in connection herewith (including without limitation the Purchase Agreement), shall be false or misleading in any material respect when made
          and the breach of which has (or with the passage of time will have) a material adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.

      

      

      3.5 [Intentionally Omitted].

      

      

      3.6 [Intentionally Omitted].

      

      

      3.7 Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings or
          other proceedings, voluntary or involuntary, for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary of the Borrower.

      

      

      3.8 Delisting of Common Stock. The Borrower shall fail to maintain the listing or
          quotation of the Common Stock on the OTCQB or an equivalent replacement exchange, the Nasdaq Global Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT.

      

      

      3.9 Failure to Comply with the Exchange Act.  The Borrower shall fail to comply with the
          reporting requirements of the Exchange Act (including but not limited to becoming delinquent in its filings), and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act.

      

      

      3.10 Liquidation.  Any dissolution, liquidation, or winding up   of Borrower or any
          substantial portion of its business.

      

      

      3.11 Cessation of Operations; Maintenance of Assets. Any cessation of operations by
          Borrower, or disposition or conveyance of any material asset of the Borrower if such disposition or conveyance would cause the Borrower to become a “shell” company.

      

      

       3.12 [Intentionally Omitted].

      

      

      3.13 Replacement of Transfer Agent. In the event that the Borrower replaces its transfer
          agent, and the Borrower fails to provide prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions (including but not limited to the provision to irrevocably reserve shares of Common Stock in the
          Reserved Amount) signed by the successor transfer agent to Borrower and the Borrower.

      

      

      3.14 Cessation of Trading.  Any cessation of trading of the Common Stock on at least one
          of the OTC Pink, OTCQB, Nasdaq National Market, Nasdaq Small Cap Market, New York Stock Exchange, NYSE MKT, or an equivalent replacement exchange, and such cessation of trading shall continue for a period of five consecutive (5) Trading Days.3.20OTC Markets Designation.  OTC Markets changes the Borrower’s designation to ‘No Information’ (Stop Sign), ‘Caveat Emptor’ (Skull and Crossbones), or ‘OTC’, ‘Other OTC’ or ‘Grey Market’ (Exclamation Mark Sign).

      

      

      3.15 Inside Information. 
          Any attempt by the Borrower or its officers, directors, and/or affiliates to transmit, convey, disclose, or any actual transmittal, conveyance, or disclosure by the Borrower or its officers, directors, and/or affiliates of, material non-public
          information concerning the Borrower, to the Holder or its successors and assigns, which is not immediately cured by Borrower’s filing of a Form 8-K pursuant to Regulation FD on that same date.

      

      

      3.16 Unavailability of Rule 144.  If, at any time on or after the date which is six (6)
          months after the Issue Date, the Holder is unable to (i) obtain a standard “144 legal opinion letter” from an attorney reasonably acceptable to the Holder, the Holder’s brokerage firm (and respective clearing firm), and the Borrower’s transfer
          agent in order to facilitate the Holder’s conversion of any portion of the Note into free trading shares of the Borrower’s Common Stock pursuant to Rule 144, and (ii) thereupon deposit such shares into the Holder’s brokerage account.

      

      

      Upon the occurrence of any Event of Default specified in Sections 3.1, 3.2, 3.3, 3.4, 3.7, 3.8, 3.9, 3.10, 3.11, 3.13, 3.14, 3.15,
        and/or 3.16 exercisable through the delivery of written notice to the Borrower by the Holder (the “Default Notice”), the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of its obligations
        hereunder, an amount equal to 125% multiplied by the then outstanding entire balance of the Note (including principal and accrued and unpaid interest) plus Default Interest, if any, plus any amounts owed to the Holder pursuant to Sections 1.4(g)
        hereof (collectively, in the aggregate of all of the above, the “Default Sum”), and all other amounts payable hereunder shall immediately become due and payable, all without demand, presentment or notice, all of which hereby are expressly waived,
        together with all costs, including, without limitation, legal fees and expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies available at law or in equity.

      

      

      The Holder shall have the right at any time to require the Borrower to issue the number of shares of Common Stock of the Borrower
        equal to the Default Sum divided by the Conversion Price then in effect, subject to issuance in tranches due to the beneficial ownership limitations contained in this Note.

      

      

      ARTICLE IV. MISCELLANEOUS

      

      

      4.1 Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in
          the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or
          privileges. All rights and remedies existing hereunder are cumulative to, and not exclusive of, any rights or remedies otherwise available.

      

      

      4.2 Notices. All notices, demands, requests, consents, approvals, and other
          communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii)
          delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, facsimile, or electronic mail addressed as set forth below or to such other address as such party shall have specified most recently by written
          notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery, upon electronic mail delivery, or delivery by facsimile, with accurate confirmation generated by the
          transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other
          than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt
          of such mailing, whichever shall first occur.  The addresses for such communications shall be:

      

      

      

      

      

      

      

      If to the Borrower, to:

      

      

      BioRestorative Therapies, Inc.

      40 Marcus Drive

      Melville, NY 11747

      Attn:  Mark Weinreb

      Facsimile:  (631) 760-8414

      E-mail:  info@biorestorative.com

      

      

      With a copy to (which copy shall not constitute notice):

      

      

      Certilman Balin Adler & Hyman, LLP

      90 Merrick Avenue

      East Meadow, NY  11554

      Attn:  Fred Skolnik, Esq.

      Facsimile:  (516) 296-7111

      Email: fskolnik@certilmanbalin.com

      

      

      If to the Holder:

      

      

      Auctus Fund, LLC

      545 Boylston Street, 2nd Floor

      Boston, MA 02116

      Attn: Lou Posner

      Facsimile: (617) 532-6420

      

      

      With a copy to (which copy shall not constitute notice):

      

      

      Chad Friend, Esq., LL.M.

      Anthony L.G., PLLC

      625 N. Flagler Drive, Suite 600

      West Palm Beach, FL 33401

      E-mail: CFriend@AnthonyPLLC.com

      

      

      4.3 Amendments. This Note and any provision hereof may only be amended by an instrument
          in writing signed by the Borrower and the Holder. The term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument as originally executed, or if later amended or supplemented, then as so amended or
          supplemented.

      

      

      4.4 Assignability. This Note shall be binding upon the Borrower and its successors and
          assigns, and shall inure to be the benefit of the Holder and its successors and assigns.  Neither the Borrower nor the Holder shall assign this Note or any rights or obligations hereunder without the prior written consent of the other. 
          Notwithstanding the foregoing, the Holder may assign its rights hereunder to any “accredited investor” (as defined in Rule 501(a) of the 1933 Act) in a private transaction from the Holder or to any of its “affiliates”, as that term is defined
          under the 1934 Act, without the consent of the Borrower.  Notwithstanding anything in this Note to the contrary, this Note may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.  The Holder and
          any assignee, by acceptance of this Note, acknowledge and agree that following conversion of a portion of this Note, the unpaid and unconverted principal amount of this Note represented by this Note may be less than the amount stated on the face
          hereof.

      

      

      4.5 Cost of Collection. If default is made in the payment of this Note, the Borrower
          shall pay the Holder hereof reasonable costs of collection, including reasonable attorneys’ fees.

      

      

      4.6 Governing Law. This Note shall be governed by and construed in accordance with the
          laws of the State of Nevada without regard to principles of conflicts of laws.  Any action brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the state courts of Massachusetts
          or in the federal courts located in the Commonwealth of Massachusetts.  The parties to this Note hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of
          jurisdiction or venue or based upon forum non conveniens.  EACH OF THE BORROWER AND THE HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS NOTE
            OR ANY TRANSACTION CONTEMPLATED HEREBY.  The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs.  In the event that any provision of this Note or any other agreement delivered in
          connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or
          rule of law.  Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.   Each party hereby irrevocably waives personal service of process
          and consents to process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
          delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in
          any way any right to serve process in any other manner permitted by law.

      

      

      4.7 Certain Amounts. Whenever pursuant to this Note the Borrower is required to pay an
          amount in excess of the outstanding principal amount (or the portion thereof required to be paid at that time) plus accrued and unpaid interest plus Default Interest on such interest, the Borrower and the Holder agree that the actual damages to
          the  Holder from the receipt of cash payment on this Note may be difficult to determine and the amount to be so paid by the Borrower represents stipulated damages and not a penalty and is intended to compensate the Holder in part for loss of the
          opportunity to convert this Note and to earn a return from the sale of shares of Common Stock acquired upon conversion of this Note at a price in excess of the price paid for such shares pursuant to this Note. The Borrower and the Holder hereby
          agree that such amount of stipulated damages is not plainly disproportionate to the possible loss to the Holder from the receipt of a cash payment without the opportunity to convert this Note into shares of Common Stock.

      

      

      4.8 Purchase Agreement.  By its acceptance of this Note, each party agrees to be bound
          by the applicable terms of the Purchase Agreement.

      

      

      4.9 Usury. If it shall be found that any interest or other amount deemed interest due
          hereunder violates the applicable law governing usury, the applicable provision shall automatically be revised to equal the maximum rate of interest or other amount deemed interest permitted under applicable law. The Borrower covenants (to the
          extent that it may lawfully do so) that it will not seek to claim or take advantage of any law that would prohibit or forgive the Borrower from paying all or a portion of the principal or interest on this Note.

      

      

      4.10 Remedies. The Borrower acknowledges that a breach by it of its obligations hereunder
          will cause irreparable harm to the Holder, by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at law for a breach of its obligations under this Note will be
          inadequate and agrees, in the event of a breach or threatened breach by the Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the
          penalties assessable herein, to an injunction or injunctions restraining,  preventing or curing any breach of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without any
          bond or other security being required.  No provision of this Note shall alter or impair the obligation of the Borrower, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the time, place, and rate, and in
          the form, herein prescribed.

      

      

      4.11 Severability.  In the event that any provision of this Note is invalid or
          unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law.  Any provision
          hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.

      

      

      4.12 Dispute Resolution. In the case of a dispute as to
          the determination of the Conversion Price, Conversion Amount, any prepayment amount or Default Amount, Default Sum, Closing or Maturity Date, the closing bid price, or fair market value (as the case may be) or the arithmetic calculation of the
          Conversion Price or the applicable prepayment amount(s) (as the case may be), the Borrower or the Holder shall submit the disputed determinations or arithmetic calculations via facsimile (i) within two (2) Business Days after receipt of the
          applicable notice giving rise to such dispute to the Borrower or the Holder or (ii) if no notice gave rise to such dispute, at any time after the Holder learned of the circumstances giving rise to such dispute. If the Holder and the Borrower are
          unable to agree upon such determination or calculation within two (2) Business Days of such disputed determination or arithmetic calculation (as the case may be) being submitted to the Borrower or the Holder, then the Borrower shall, within two
          (2) Business Days, submit via facsimile (a) the disputed determination of the Conversion Price, the closing bid price, the or fair market value (as the case may be) to an independent, reputable investment bank selected by the Borrower and
          approved by the Holder or (b) the disputed arithmetic calculation of the Conversion Price, Conversion Amount, any prepayment amount or Default Amount, Default Sum to an independent, outside accountant selected by the Holder that is reasonably
          acceptable to the Borrower. The Borrower shall cause at its expense the investment bank or the accountant to perform the determinations or calculations and notify the Borrower and the Holder of the results no later than ten (10) Business Days
          from the time it receives such disputed determinations or calculations. Such investment bank’s or accountant’s determination or calculation shall be binding upon all parties absent demonstrable error.

      4.13 Terms of Future Financings.  So long as this Note is outstanding, upon any issuance
          by the Borrower or any of its subsidiaries of any security with conversion discounts more favorable to the holder of such security, then the Borrower shall notify the Holder of such additional or more favorable term and such term, at Holder’s
          option, shall become a part of the transaction documents with the Holder.

      

      

      4.14 Piggyback Registration Rights.

      

      

      (a) In the event the Borrower shall determine to file a Registration Statement under the Act (other than on Form S-4 or Form S-8 or another form not available for registering the
          Borrower’s Common Stock for sale to the public) in connection with the proposed offer and sale of any of its securities, the Borrower shall give written notice of its determination to the Holder (a “Piggyback Notice”). In the event the Holder,
          within twenty (20) days after the receipt of the Piggyback Notice, shall notify the Borrower of its desire that the shares of Common Stock issuable upon conversion of this Note (the “Conversion Shares”) be included in the Registration Statement,
          the Borrower shall include such Conversion Shares in the Registration Statement, all to the extent requisite to permit the sale or other disposition by the Holder of the Conversion Shares to be so registered; provided, however, that the Borrower
          may at any time, in its sole discretion, withdraw or cease proceeding with any such registration.

      

      

      (b) If the registration with respect to which the Borrower gives the Piggyback Notice is for a public offering involving an underwriting, the Borrower agrees to so advise the
          Holder as a part of its written notice.  In such event, the right of the Holder to registration pursuant to this Section 4.14 shall be conditioned upon the Holder's participation in such underwriting and the inclusion of the Holder’s Conversion
          Shares in the underwriting to the extent required by the managing underwriter.  In such event, the Holder shall enter into an underwriting agreement with the underwriter or underwriters selected for such underwriting by the Borrower on terms that
          are acceptable to the Borrower.

      

      

      (c) Notwithstanding any other provision of this Section 4.14, if the managing underwriter of an underwritten distribution or placement agent of a best efforts offering advises the
          Borrower and the Holder in writing that in its good faith judgment the number of Conversion Shares requested to be registered under this Section 4.14 and other securities requested to be registered exceeds the number of shares of Common Stock and
          other securities which can be sold in such offering without adversely affecting the success of such offering or the price at which such securities are offered, then (i) the number of Conversion Shares and other securities (except for shares to be
          issued by the Borrower for its own account) so requested to be included in the offering shall be reduced to that number of shares which in the good faith judgment of the managing underwriter or placement agent can be sold in such offering, and
          (ii) such reduced number of shares, if any, shall be allocated among the Holder and holders of other securities in proportion, as nearly as practicable, to the respective number of Conversion Shares and other securities requested by the Holder
          and other holders to be included in the Registration Statement.

      

      

      (d) Notwithstanding the foregoing, the Borrower need not send a Piggyback Notice if the Conversion Shares are then saleable pursuant to Rule 144.

      

      

      

      

      [signature page to follow]

       

      

      

      
        
          

      

      IN WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer this October 7, 2019.

      

      

      BIORESTORATIVE THERAPIES, INC.

      

      

      By: 

      Name: Mark Weinreb

      Title: Chief Executive Officer

       

      

      
        
          

      

      EXHIBIT A

      NOTICE OF CONVERSION

      

      

      The undersigned hereby elects to convert $  principal amount of the Note (defined below) together with $  of accrued and unpaid interest thereto, totaling $_____________ into that number of shares of Common Stock to be issued pursuant to the conversion of the Note (“Common Stock”) as set forth
          below, of BioRestorative Therapies, Inc., a Delaware corporation (the “Borrower”), according to the conditions of the convertible note of the Borrower dated as of October 7, 2019 (the “Note”), as of the date written below.  No fee will be charged
          to the Holder for any conversion, except for transfer taxes, if any.

      

      

      Box Checked as to applicable instructions:

      

      

      
        
          	[ ]	
                  The Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned or its nominee with
                    DTC through its Deposit Withdrawal At Custodian system (“DWAC Transfer”).

                

        

      

      

      

      Name of DTC Prime Broker:

      Account Number:

      

      

      
        
          	[  ]	
                  The undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth below (which numbers are
                    based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or, if additional space is necessary, on an attachment hereto:

                

        

      

      

      

      Name: [NAME]

      Address: [ADDRESS]

      

      

      Date of Conversion:  

      Applicable Conversion Price: $ 

      Number of Shares of Common Stock to be Issued

       Pursuant to Conversion of the Notes:  

      Amount of Principal Balance Due remaining

       Under the Note after this conversion:  

      Accrued and unpaid interest remaining:  

      

      

      [HOLDER]

      

      

      

      

      By: 

      Name: 

      Title: 

      Date:NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
      SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
      STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
      OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
      ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

    

    

    

    

    COMMON STOCK PURCHASE WARRANT

    

    

    BIORESTORATIVE THERAPIES, INC.

    

    

    Warrant Shares: 100,000

    Date of Issuance:  October 7, 2019 (“Issuance Date”)

    

    

    This COMMON STOCK PURCHASE WARRANT (the “Warrant”)
      certifies that, for value received (in connection with the issuance of the convertible promissory note in the principal amount of $850,000.00 issued to the Holder (as defined below) of even date) (the “Note”), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”),
      is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), up to 100,000 shares of Common Stock (as defined below) (the “Warrant
          Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect.  This Warrant is issued by the Company as of the date hereof in
      connection with that certain securities purchase agreement dated October 7, 2019, by and between the Company and the Holder (the “Purchase Agreement”).

    

    

    Capitalized terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body
      of this Warrant or in Section 12 below.  For purposes of this Warrant, the term “Exercise Price” shall mean $0.35, subject to adjustment as provided herein
      (including but not limited to cashless exercise), and the term “Exercise Period” shall mean the period commencing on the Issuance Date and ending on 5:00 p.m.
      eastern standard time on the five-year anniversary thereof.

    

    

    1. EXERCISE OF WARRANT.

    

    

    (a) Mechanics of Exercise.  Subject to the terms and conditions hereof, the
        rights represented by this Warrant may be exercised in whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant.  The Holder shall not be required to
        deliver the original Warrant in order to effect a partial exercise hereunder.  Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the
        outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.  On or before the third Trading Day (the “Warrant Share Delivery Date”) following the date on which the Company shall have received the Exercise Notice, and upon receipt by the Company of payment to the Company of an amount equal to the applicable Exercise Price
        multiplied by the number of Warrant Shares as to which all or a portion of this Warrant is being exercised (the “Aggregate Exercise Price” and together with
        the Exercise Notice, the “Exercise Delivery Documents”) in cash or by wire transfer of immediately available funds (or by cashless exercise, in which case
        there shall be no Aggregate Exercise Price provided), the Company shall (or direct its transfer agent to) issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the Company’s share
        register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise.  Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate
        purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing such Warrant Shares.  If this Warrant is submitted in
        connection with any exercise and the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no
        event later than three Business Days after any exercise and at its own expense, issue a new Warrant (in accordance with Section 6) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under
        this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised.

    

    

    If the Company fails to cause its transfer agent to transmit to the Holder the respective shares of Common Stock by the respective
      Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise in Holder’s sole discretion, and such failure shall be deemed an event of default under the Note.

    

    

    If the Market Price of one share of Common Stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares
      pursuant to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below (or of any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in which
      event the Company shall issue to Holder a number of shares of Common Stock computed using the following formula:

    

    

    X = Y
          (A-B)

    A

    Where X = the number of Shares to be issued to Holder.

    
      
        	

              	  Y =	
                the number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).

              

      

    

    A = the Market Price (at the date of such calculation).

    B = Exercise Price (as adjusted to the date of such calculation).

    

    

    (b) No Fractional Shares.  No fractional shares shall be issued upon the
        exercise of this Warrant as a consequence of any adjustment pursuant hereto.  All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result in the
        issuance of any fractional share.  If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in
        cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.

    

    

    (c) Holder’s Exercise Limitations.  The Company shall not effect any exercise
        of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, to the extent that after giving effect to issuance of Warrant Shares upon exercise as set forth on the applicable Notice of Exercise, the Holder
        (together with the Holder’s Affiliates, and any other persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation, as defined below.  For purposes of
        the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
        being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or
        conversion of the unexercised or non-converted portion of any other securities of the Company (including without limitation any other  Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained
        herein beneficially owned by the Holder or any of its Affiliates.  Except as set forth in the preceding sentence, for purposes of this paragraph (d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act, it
        being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
        accordance therewith.   To the extent that the limitation contained in this paragraph applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates) and of which
        portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other
        securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the
        accuracy of such determination.

    

    

    For purposes of this paragraph, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
      outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the
      Company or its transfer agent setting forth the number of shares of Common Stock outstanding.  Upon the request of a Holder, the Company shall within two Trading Days confirm to the Holder the number of shares of Common Stock then outstanding.  In
      any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its affiliates since the date as of which such
      number of outstanding shares of Common Stock was reported.  The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock
      outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.  The limitations contained in this paragraph shall apply to a successor Holder of this Warrant.

    

    

    2. ADJUSTMENTS.  The Exercise Price and the number of Warrant Shares shall be adjusted
        from time to time as follows:

    

    

    (a) Distribution of Assets.  If the Company shall declare or make any
        dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation any distribution of cash, stock or other securities,
        property or options by way of a dividend, spin off, reclassification, corporate rearrangement or other similar transaction, but not including a stock split, stock dividend or reverse stock split with respect to the Common Stock) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, any Exercise Price in effect immediately prior to the close of business
        on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a price determined by multiplying such Exercise
        Price by a fraction (i) the numerator of which shall be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in good faith by the Company’s
        Board of Directors) applicable to one share of Common Stock, and (ii) the denominator of which shall be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date.

    

    

    (b) Adjustments for Stock Dividends; Combinations, Etc. 
        In case the Company shall do any of the following (an “Event”):

    (i) declare a dividend or other distribution on its shares of Common Stock payable in shares of Common Stock of the Company,

    (ii) subdivide the outstanding shares of Common Stock pursuant to a stock split or otherwise, or

    (iii) combine the outstanding shares of Common Stock into a smaller number of shares pursuant to a reverse split or otherwise,

    then the Exercise Price in effect at the time of the record date for such dividend or other distribution or of the effective date of
      such subdivision or combination shall be changed to a price determined by dividing (a) the product of the number of shares of Common Stock outstanding immediately prior to such Event, multiplied by the Exercise Price in effect immediately prior to
      such Event by (b) the number of shares of Common Stock outstanding immediately after such Event.  Each such adjustment of the Exercise Price shall be calculated to the nearest one-hundredth of a cent.  Such adjustment shall be made successively
      whenever any Event listed above shall occur.  Whenever the Exercise Price is adjusted as set forth in this Section 2(b) (whether or not the Company then or thereafter elects to issue additional Warrants in substitution for an adjustment in the number
      of shares of Warrant Stock), the number of Warrant Shares specified in each Warrant which the Holder may purchase shall be adjusted, to the nearest full share, by multiplying such number of Warrant Shares immediately prior to such adjustment by a
      fraction, of which the numerator shall be the Exercise Price immediately prior to such adjustment and the denominator shall be the Exercise Price immediately thereafter.

    (c) Anti-Dilution Adjustments to Exercise Price. 
        If the Company shall issue warrants to investors pursuant to the underwritten public offering contemplated by the registration statement filed on Form S-1 by the Company on April 26, 2019 entitling the investors to acquire shares of Common Stock
        (the “Public Warrants”) at an exercise price per share less than the then Exercise Price (such lower price, the “Base Share Price”) then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal the Base Share Price. The Company shall notify the Holder in writing, no later than
        the third Trading Day following the issuance of any Public Warrants of the issuance thereof and the Base Share Price (the “Public Warrant Issuance Notice”). 
        For purposes of clarification, whether or not the Company provides a Public Warrant Issuance Notice pursuant to this Section 2(c), in the event of any issuance of such Public Warrants, the Holder shall be entitled to receive Warrant Shares based
        upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise.

    3. FUNDAMENTAL TRANSACTIONS.  If, at any time while this Warrant is outstanding, (i) the
        Company effects any merger of the Company with or into another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”),
        (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender offer or exchange offer (whether by the Company or by another individual or entity, and approved by the
        Company) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iv)
        the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a
        subdivision or combination of shares of Common Stock) (in any such case, a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant,
        the Holder shall have the right to receive the number of shares of Common Stock of the Successor Entity or of the Company and any additional consideration (the “Alternate
            Consideration”) receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of the number of shares of Common Stock for which this Warrant is exercisable
        immediately prior to such event (disregarding any limitation on exercise contained herein solely for the purpose of such determination).  For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to
        apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
        Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
        Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.  To the extent necessary to effectuate the foregoing provisions, any
        Successor Entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise such warrant into Alternate Consideration.

    

    

    4. NON-CIRCUMVENTION.  The Company covenants and agrees that it will not, by amendment of
        its certificate of incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance
        or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder.  Without limiting the generality of the
        foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in
        order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved, free from
        preemptive rights, a sufficient number of shares of Common Stock that are actually issuable upon full exercise of the Warrant without regard to any limitations on exercise).

    

    

    5. WARRANT HOLDER NOT DEEMED A STOCKHOLDER.  Except as otherwise specifically provided
        herein, this Warrant, in and of itself, shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company.  In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder
        to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

    

    

    6. REISSUANCE.

    

    

    (a) Lost, Stolen or Mutilated Warrant.  If this Warrant is lost, stolen,
        mutilated or destroyed, the Company will, on such terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as
        this Warrant so lost, stolen, mutilated or destroyed.

    

    

    (b) Issuance of New Warrants.  Whenever the Company is required to issue a
        new Warrant pursuant to the terms of this Warrant, such new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date.

    

    

    7. TRANSFER.

    

    

    (a) Notice of Transfer.  The Holder agrees to give written notice to the
        Company before transferring this Warrant or transferring any Warrant Shares of such Holder’s intention to do so, describing briefly the manner of any proposed transfer.  Promptly upon receiving such written notice, the Company shall present copies
        thereof to the Company’s counsel.  If the proposed transfer may be effected without registration or qualification (under any federal or state securities laws), the Company, as promptly as practicable, shall notify the Holder thereof, whereupon the
        Holder shall be entitled to transfer this Warrant or to dispose of Warrant Shares received upon the previous exercise of this Warrant, all in accordance with the terms of the notice delivered by the Holder to the Company; provided, however, that an
        appropriate legend may be endorsed on this Warrant or the certificates for such Warrant Shares respecting restrictions upon transfer thereof necessary or advisable in the opinion of counsel and satisfactory to the Company to prevent further
        transfers which would be in violation of Section 5 of the Securities Act and applicable state securities laws; and provided further that the prospective transferee or purchaser shall execute the Assignment of Warrant attached hereto as Exhibit B and such other documents and make such representations, warranties, and agreements as may be required solely to comply with the exemptions relied upon
        by the Company for the transfer or disposition of the Warrant or Warrant Shares.

    

    

    (b) If the proposed transfer or disposition of this Warrant or such Warrant Shares described in the written notice given pursuant to this Section 7 may not be effected without
        registration or qualification of this Warrant or such Warrant Shares, the Holder will limit its activities in respect to such transfer or disposition as are permitted by law.

    

    

    (c) Any transferee of all or a portion of this Warrant shall succeed to the rights and benefits of the initial Holder of this Warrant under Sections 4.1 and 4.3 (subject, however,
        to the limitations set forth in Section 4.2), 4.4 and 4.5 of the Purchase Agreement (registration rights, expenses, and indemnity).

    

    

    8. NOTICES.  Whenever notice is required to be given under this Warrant, unless otherwise
        provided herein, such notice shall be given in accordance with the notice provisions contained in the Purchase Agreement.  The Company shall provide the Holder with prompt written notice (i) immediately upon any adjustment of the Exercise Price,
        setting forth in reasonable detail, the calculation of such adjustment and (ii) at least 20 days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the shares of Common
        Stock, (B) with respect to any grants, issuances or sales of any stock or other securities directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock or other property, pro rata to the holders of shares of
        Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with such notice
        being provided to the Holder.

    

    

    9. AMENDMENT AND WAIVER.  The terms of this Warrant may be amended or waived (either
        generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Holder.

    

    

    10. GOVERNING LAW.  This Warrant shall be governed by and construed in accordance with the
        laws of the State of Nevada without regard to principles of conflicts of laws.  Any action brought by either party against the other concerning the transactions contemplated by this Warrant shall be brought only in the state courts of Massachusetts
        or in the federal courts located in the Commonwealth of Massachusetts.  The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack
        of jurisdiction or venue or based upon forum non conveniens.  THE BORROWER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION
          CONTEMPLATED HEREBY.  The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs.  In the event that any provision of this Warrant or any other agreement delivered in connection herewith
        is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law.  Any
        such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.   Each party hereby irrevocably waives personal service of process and consents to
        process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at
        the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve
        process in any other manner permitted by law.

    

    

    11. ACCEPTANCE.  Receipt of this Warrant by the Holder shall constitute acceptance of and
        agreement to all of the terms and conditions contained herein.

    

    

    12. CERTAIN DEFINITIONS.  For purposes of this Warrant, the following terms shall have the
        following meanings:

    

    

    (a) “Nasdaq” means www.Nasdaq.com.

    

    

    (b) “Closing Sale Price” means, for any security as of any date, (i) the last closing
        trade price for such security on the Principal Market, as reported by Nasdaq or such Principal Market, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing trade price, then the last trade
        price of such security prior to 4:00 p.m., New York time, as reported by Nasdaq or such Principal Market, or (ii) if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such security as reported by
        Nasdaq or such Principal Market, or (iii) if no last trade price is reported for such security by Nasdaq or such Principal Market, the average of the bid and ask prices of any market makers for such security as reported by the OTC Markets.  If the
        Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. 
        All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

    

    

    (c) “Common Stock” means the Company’s common stock, and any other class of securities
        into which such securities may hereafter be reclassified or changed.

    

    

    (d) “Common Stock Equivalents” means any securities of the Company that would entitle the
        holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles
        the holder thereof to receive, Common Stock.

    

    

    (e) “Principal Market” means the primary national securities exchange on which the Common
        Stock is then traded.

    

    

    (h) “Market Price” means the Closing Sale Price of the Common Stock on the  Trading Day
        immediately prior to the date of the respective Exercise Notice.

    

    

    (i) “Trading Day” means (i) any day on which the Common Stock is listed or quoted and
        traded on its Principal Market, (ii) if the Common Stock is not then listed or quoted and traded on any national securities exchange, then a day on which trading occurs on any over-the-counter markets, or (iii) if trading does not occur on the
        over-the-counter markets, any Business Day.

    

    

    

    

    

    

    *  *  *  *  *  *  *

    

    

    

    

    
      
        

    

    IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

    

    

    

    

    BIORESTORATIVE THERAPIES, INC.

    

    

    

    

    

    

     

    Name: Mark Weinreb

    Title: Chief Executive Officer

    

    

    

    

    
      
        

    

    EXHIBIT A

    

    

    EXERCISE NOTICE

    

    

    (To be executed by the registered holder to exercise this Common Stock Purchase Warrant)

    

    

    

    

    The Undersigned holder
      hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”) of BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), evidenced by the attached copy of the Common Stock Purchase Warrant
      (the “Warrant”).  Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

    

    

    
      
        	1.	
                Form of Exercise Price.  The Holder intends that payment of the Exercise
                  Price shall be made as (check one):

              

      

    

    

    

    ☐ a cash exercise with respect to _________________ Warrant Shares; or

    ☐  by cashless exercise pursuant
      to the Warrant.

    

    

    

    

    
      
        	2.	
                Payment of Exercise Price.  If cash exercise is selected above, the
                  holder shall pay the applicable Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the Warrant.

              

      

    

    

    

    
      
        	3.	
                Delivery of Warrant Shares.  The Company shall deliver to the holder
                  __________________ Warrant Shares in accordance with the terms of the Warrant.

              

      

    

    

    

    

    

    

    

    Date: 

    

    

    

    

     

    

    (Print Name of Registered Holder)

    

    

    

    

    By: 

    Name: 

    Title: 

    

    

    
      
        

    

    EXHIBIT B

    

    

    ASSIGNMENT OF WARRANT

    

    

    (To be signed only upon authorized transfer of the Warrant)

    

    

    

    

    For Value Received, the
      undersigned hereby sells, assigns, and transfers unto ____________________ the right to purchase _______________ shares of common stock of BioRestorative Therapies, Inc., to which the within Common Stock Purchase Warrant relates and appoints
      ____________________, as attorney-in-fact, to transfer said right on the books of BioRestorative Therapies, Inc. with full power of substitution and re-substitution in the premises.  By accepting such transfer, the transferee has agreed to be bound
      in all respects by the terms and conditions of the within Warrant.

    

    

    

    

    

    

    Dated:  __________________

    

    

    

    

     

    

    (Signature) *

    

    

     

    

    (Name)

    

    

     

    

    (Address)

    

    

     

    

    (Social Security or Tax Identification No.)

    

    

    

    

    

    

    * The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Stock Purchase Warrant in every particular
      without alteration or enlargement or any change whatsoever.  When signing on behalf of a corporation, partnership, trust or other entity, please indicate your position(s) and title(s) with such entity.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]